Results 11 to 20 of about 87,487 (309)

The postfinasteride syndrome; an overview [PDF]

, 2016
As a 5-α reductase inhibitor, Finasteride has proven effective in ameliorating two conditions documented to be androgen dependent, namely male androgenic alopecia and benign prostatic hyperplasia. Therapeutic results are maintained as long as the drug is
Banu, Petrisor, Bălălău, Cristian, Constantin, Vlad D., Motofei, Ion G., Popa, Florian, Păunică, Georgeta P., Păunică, Ioana, Păunică, Stana, Rowland, David L., Vasilache, Adriana   +9 more
core   +11 more sources

Correlation of international prostatic symptom score with prostate volume

Journal of Rawalpindi Medical College, 2023
Objective: To evaluate the correlation of International Prostatic Symptom Score with Prostate Volume of Benign Prostatic Hyperplasia patients. Study Design: A Cross- out sectional study was done.
Iffat Raza, Maria Mohiuddin, Syeda Bushra Ahmed, Mubina Lakhani, Sahrish Mukhtar, Nuzhat Hassan   +5 more
doaj   +1 more source

Profile in ganglioside antibodies in benign prostatic hyperplasia [PDF]

Romanian Journal of Neurology, 2016
Molecular pathology of benign prostatic hyperplasia is multifactorial and involves endocrine, biochemical, immunological interactions. The mechanisms involved in the onset and progression of benign prostatic hyperplasia are: infections, older than 50 ...
Ilinca Nicolae, Corina-Daniela Ene, Mirela Petrescu, Simona Roxana Georgescu   +3 more
doaj   +1 more source

Benign prostatic hyperplasia [PDF]

Nature Reviews Disease Primers, 2016
Benign prostatic hyperplasia (BPH), which causes lower urinary tract symptoms (LUTS), is a common diagnosis among the ageing male population with increasing prevalence. Many risks factors, both modifiable and non-modifiable, can increase the risk of development and progression of BPH and LUTS.
Bilal, Chughtai, James C, Forde, Dominique Dana Marie, Thomas, Leanna, Laor, Tania, Hossack, Henry H, Woo, Alexis E, Te, Steven A, Kaplan   +7 more
openaire   +4 more sources

Monotherapy versus combination therapy in the treatment of benign prostatic hyperplasia: A single center study

Zanco Journal of Medical Sciences, 2020
Background and objectives: Most benign prostatic hyperplasia patients do not present obvious indicators for surgical intervention, so most of these patients are treated initially with medical therapy.
Wishyar Jamal Al-Bazzaz, Omar W. Alkhayat, Ali W. AlKhayat W. AlKhayat   +2 more
doaj   +1 more source

DECOMPENSATED URINARY BLADDER DUE TO BENIGN PROSTATIC HYPERPLASIA (LITERATURE REVIEW)

Проблеми екології та медицини, 2022
We conducted an analytical review of the literature on the problem of bladder decompensation in patients with benign prostatic hyperplasia. Benign prostatic hyperplasia is one of the most common diseases in aging men. As is known, with the development of
O.O. Sherstyuk, Y.V. Sarychev, S.M. Suprunenko, S.A. Sukhomlin, G.L. Pustovoit   +4 more
doaj   +1 more source

Benign prostatic hyperplasia : Part 1- diagnosis [PDF]

, 2008
Peer reviewedPublisher ...
N'Dow, James Michael Olu, Wilt, Timothy
core   +2 more sources

Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle. [PDF]

, 2012
The transcription factors Elk1 and serum response factor (SRF) are central regulators of cell cycle and phenotype in various cell types. Elk1 is activated by phosphorylation (serine-383), while activation of SRF requires its co-factor, myocardin ...
Andersson, Karl-Erik, Beckmann, Christer, Füllhase, Claudius, Gratzke, Christian, Hedlund, Petter, Hennenberg, Martin, Montorsi, Francesco, Rutz, Beata, Stief, Christian Georg, Strittmatter, Frank, Waidelich, Raphaela   +10 more
core   +2 more sources

Immunohistochemical Expression of Nkx3.1 in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia at a Tertiary Care Hospital in Karachi

Journal of Gandhara Medical and Dental Sciences, 2023
OBJECTIVES To determine NKX3.1 expression in prostatic adenocarcinoma and benign prostate hyperplasia on Immunohistochemistry at a tertiary care hospital in Karachi.
Beenish Hussain, Syeda Naveera Raza, Amna Hussain, Ramsha Faridi, Saman Nadeem, Yusra Saleem   +5 more
doaj   +1 more source

Interstitial laser therapy of benign prostatic hyperplasia [PDF]

, 1999
The objective of interstitial laser coagulation (ILC) of benign prostatic enlargement is to achieve a marked volume reduction and to decrease bladder outlet obstruction and lower urinary tract symptoms with minimal morbidity.
Muschter, Rolf, Whitfield, Hugh
core   +1 more source